Synopsis
0
CEP/COS
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Jai Radhe Sales is your partner for all your sourcing needs.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Disintegrants & Superdisintegrants
Chewable & Orodispersible Aids
Granulation
Co-Processed Excipients
Taste Masking
Thickeners and Stabilizers
Coating Systems & Additives
Lubricants & Glidants
Film Formers & Plasticizers
Controlled & Modified Release
Parenteral
Emulsifying Agents
Rheology Modifiers
API Stability Enhancers
Solubilizers
Topical
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
77
PharmaCompass offers a list of Rasagiline Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rasagiline Mesylate manufacturer or Rasagiline Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rasagiline Mesylate manufacturer or Rasagiline Mesylate supplier.
PharmaCompass also assists you with knowing the Rasagiline Mesylate API Price utilized in the formulation of products. Rasagiline Mesylate API Price is not always fixed or binding as the Rasagiline Mesylate Price is obtained through a variety of data sources. The Rasagiline Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate, including repackagers and relabelers. The FDA regulates (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate supplier is an individual or a company that provides (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate active pharmaceutical ingredient (API) or (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate finished formulations upon request. The (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate suppliers may include (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate API manufacturers, exporters, distributors and traders.
click here to find a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate DMF (Drug Master File) is a document detailing the whole manufacturing process of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate active pharmaceutical ingredient (API) in detail. Different forms of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate DMFs exist exist since differing nations have different regulations, such as (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate DMF submitted to regulatory agencies in the US is known as a USDMF. (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate USDMF includes data on (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate Drug Master File in Korea ((1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate. The MFDS reviews the (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate KDMF as part of the drug registration process and uses the information provided in the (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate KDMF to evaluate the safety and efficacy of the drug.
After submitting a (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate suppliers with KDMF on PharmaCompass.
A (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate written confirmation ((1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate WC) is an official document issued by a regulatory agency to a (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate manufacturer, verifying that the manufacturing facility of a (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate APIs or (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate finished pharmaceutical products to another nation, regulatory agencies frequently require a (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate WC (written confirmation) as part of the regulatory process.
click here to find a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate suppliers with NDC on PharmaCompass.
(1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate GMP manufacturer or (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate GMP API supplier for your needs.
A (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate CoA (Certificate of Analysis) is a formal document that attests to (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate's compliance with (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate specifications and serves as a tool for batch-level quality control.
(1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate CoA mostly includes findings from lab analyses of a specific batch. For each (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate may be tested according to a variety of international standards, such as European Pharmacopoeia ((1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate EP), (1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((1R)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine methanesulfonate USP).
